References
- Jones RN, Barry AL. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S: SCH 39720), a new orally administered cephalosporin. Antimicrob Agents Chemother, 1988; 32: 1576–82.
- Jones RN, Barry AL, Allen SD et al. Ceftibuten (7432-S, SCH 39720) comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines. Eur J Clin Microbiol Infect Dis, 1988; 7: 802–7.
- Barr WH, Lin CC, Radwanski E, Lim J, Symchowicz S, Affrime M. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis, 1991; 14: 93–100.
- Wise R, Nye K, O’Neill P, Wostenholme M, Andrews JM. Pharmacokinetics and tissue penetration of ceftibuten. Antimicrob Agents Chemother, 1990; 34: 1053–5.
- Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus cefaclor for the treatment of bronchitis. J Antimicrob Chemother, 1991; 28: 577–80.
- Hayashi I, Onuma K, Hasuike M, Ishii T. Clinical examination of ceftibuten in acute bronchitis. Jpn J Antibiot, 1990; 43: 761–7.
- Kammer RB, Ress R. Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections. Diagn Microbiol Infect Dis, 1991; 14: 101–5.
- Watanabe A, Oizumi K, Motomiya M et al. Therapeutic efficacy of ceftibuten in chronic respiratory tract infections. Jpn J Antibiot, 1990; 43: 768–78.
- Hashimoto H, Yamaguchi S, Yachiku S. Clinical studies of ceftibuten in the field of urology. Jpn J Antibiot, 1990; 43: 355–61.
- Mizutani S, Nishimura K, Yoshimura K et al. Clinical experience with ceftibuten in complicated urinary tract infections. Jpn J Antibiot, 1990; 43: 779–89.